NDC 63629-7269 Buprenorphine Hcl And Naloxone Hcl
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 63629 - Bryant Ranch Prepack
- 63629-7269 - Buprenorphine Hcl And Naloxone Hcl
Product Packages
NDC Code 63629-7269-1
Package Description: 30 TABLET in 1 BOTTLE
Product Details
What is NDC 63629-7269?
What are the uses for Buprenorphine Hcl And Naloxone Hcl?
What is the NDC to RxNorm Crosswalk for Buprenorphine Hcl And Naloxone Hcl?
- RxCUI: 351266 - buprenorphine HCl 2 MG / naloxone HCl 0.5 MG Sublingual Tablet
- RxCUI: 351266 - buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet
- RxCUI: 351266 - buprenorphine 2 MG (as buprenorphine HCl) / naloxone 0.5 MG (as naloxone HCl) Sublingual Tablet
- RxCUI: 351267 - buprenorphine HCl 8 MG / naloxone HCl 2 MG Sublingual Tablet
- RxCUI: 351267 - buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet
* Please review the disclaimer below.
Patient Education
Buprenorphine Sublingual and Buccal (opioid dependence)
Buprenorphine and the combination of buprenorphine and naloxone are used to treat opioid dependence (addiction to opioid drugs, including heroin and narcotic painkillers). Buprenorphine is in a class of medications called opioid partial agonist-antagonists and naloxone is in a class of medications called opioid antagonists. Buprenorphine alone and the combination of buprenorphine and naloxone work to prevent withdrawal symptoms when someone stops taking opioid drugs by producing similar effects to these drugs.
[Learn More]
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".